↓ Skip to main content

Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

Overview of attention for article published in Seminars in Immunopathology, September 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#48 of 559)
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
8 X users
patent
6 patents

Citations

dimensions_citation
199 Dimensions

Readers on

mendeley
131 Mendeley